- Published at
- by gurufocus.com
mixed
mixed
Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis | CRDL Stock News
\n Cardiol Therapeutics (CRDL) has commenced its pivotal Phase III MAVERIC trial with the enrollment of the first patient. The trial will assess the effica